Donafenib and sintilimab combined with hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma: a prospective, single-arm phase II trial (DoHAICs study)

ABSTRACT:

SUBMITTER: Gao W 

PROVIDER: S-EPMC12138396 | biostudies-literature | 2025 May

REPOSITORIES: biostudies-literature